Morepen Labs gets stay from Himachal High Court on GST refund notice
Morepen Laboratories Limited received a stay from the Himachal Pradesh High Court on a Show Cause Notice regarding an alleged excess GST refund claim of ₹117.94 crore. The High Court's order, received on January 8, 2026, stays the operation of the notice, with no impact on the company's financials or operations.
The High Court has granted a stay on the Show Cause Notice, and the company stated that there is no impact on its financials, operations, or other activities in view of this stay.
The company received a favorable order from the High Court, granting a stay on a Show Cause Notice, which is a positive development.
Morepen Laboratories Limited announced that the Hon'ble High Court of Himachal Pradesh at Shimla has granted a stay on the operation of a Show Cause Notice (SCN) issued by the Office of the Commissioner, Central GST & Central Excise Commissionerate, Shimla. The company had received this SCN on December 4, 2025, and subsequently filed a writ petition challenging it.
The Hon'ble High Court, in its order dated January 6, 2026, which was received by the company on January 8, 2026, at 2:55 p.m., allowed the company's petition and granted the stay. The SCN had alleged that Morepen Laboratories erroneously claimed an excess GST refund amounting to ₹117,94,03,452/- under Section 54 of the CGST Act, 2017, read with Rule 89(4) of CGST Rules.
In view of the stay granted by the High Court, there is no immediate impact on the company's financials, operations, or other activities.
What to do with a filing like this
Morepen Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Morepen Laboratories Limited. Read the original for the full detail.